Whole-body MRI is trending, but is it right for you?

Whole-body MRI is trending, but is it right for you?

Our perspective on the limitations, uses cases and clinical considerations for whole-body MRI 

By Shaun Francis, Chair and CEO of Medcan

These days, whole-body MRI seems like it's everywhere. It shows up in our news feeds, often endorsed by high-profile celebrities, and is increasingly being promoted by wellness companies and influencers as a powerful tool for early detection. 

As interest has grown, so have the questions we've been receiving from clients. Many are curious about whether whole-body MRI is right for them.

On one level, I find this whole-body MRI trend encouraging. It signals a meaningful shift where more people are thinking about their health proactively. The idea of a radiation-free scan that can look for cancers, aneurysms, organ changes and spinal issues before symptoms appear, is understandably compelling.

But as with any emerging trend in healthcare, interest needs to be balanced with understanding and clinical validity. This is where clinical expertise and evidence-based facts on a longevity tool that’s trending become essential. 

While celebrity endorsements may bring attention to these technologies, they don’t replace evidence-based expert guidance. As demand continues to grow, I believe it’s our responsibility to ensure people have clear, credible information to make informed decisions about their health. In that light, Medcan has a distinct clinical point of view on this topic, and so we’ve shared our detailed guidance below.  

Like any medical test, whole-body MRI has both benefits and limitations. And this is why, at Medcan, it’s viewed as one part of a broader proactive health strategy, not a stand-alone solution.

It’s also important to note that it is not the ‘silver bullet’ of early detection that many may have heard. There are other tests that can be just as, if not more, powerful when it comes to asymptomatic early detection in healthy individuals. For that reason, we recommend discussing whether whole-body MRI is right for you with one of our physicians, if you are a Medcan client, or with your family doctor. 

This article outlines what you need to know about whole-body MRI, following Medcan's evidence-based clinical perspective on the topic.

What is whole-body MRI? 

Whole-body MRI – clinically known as Whole Body Magnetic Resonance Imaging – is a non-invasive form of imaging technology that scans the head, neck, chest, abdomen, pelvis and skeleton in a single session that lasts about 1 hour.  

In the simplest terms, here’s how it works: it’s a doughnut-shaped machine with a table that slowly moves inside it. You lie on the table and as your body moves through the machine, it is scanned using a combination of radio waves and a powerful magnetic field. The signals are sent to software that creates high-resolution images of the inside of your body. 

The primary use and clinical rationale for it is early detection. Whole-body MRI can detect structural changes across multiple organs including tumours, aneurysms and spinal abnormalities, and often before symptoms appear.  

Many serious conditions, including cancer and organ degeneration, can develop silently and may not cause symptoms until they are advanced. Therefore, identifying abnormalities before symptoms appear can create opportunities for earlier intervention and potentially improved outcomes. Whole-body MRI is one such solution for this early detection – but it is not the only one. 

Another major advantage of whole-body MRI is that it does not involve ionizing radiation, which means it can be safely repeated over time for ongoing surveillance. Whole-body MRI machines are unlike CT scans - which are also powerful diagnostic tools -but ones that come with trade-offs.  

With a CT scan, each scan exposes the body to ionizing radiation, which carries a small, cumulative risk of cancer over time. While the risk from a single scan is very low, repeated or unnecessary imaging can increase that risk, especially in younger individuals. In some cases, when contrast dye is used, it can cause rare allergic or kidney-related side effects. 

Whole-body MRI, on the other hand, uses strong magnetic fields and radiofrequency pulses to create high-resolution images of soft tissue, rather than x-rays. It also does not often use radioactive tracers such as contrast dyes, especially for prevention. However, in certain cases, a radiologist may still use a dye to more deeply see tumours or abnormal tissue, inflammation, blood vessels or blood flow.  

But for most whole-body MRI for proactive preventative use, this is not the case and why it’s become particularly popular and relevant for health-conscious individuals interested in prevention and periodic monitoring. For instance, the whole-body MRI provider Medcan refers clients to does not use radioactive tracers. 

Safe, proactive and fast – sounds incredible. But is there a catch? 

Whole-body MRI is highly sensitive for detecting abnormalities, and that sensitivity comes with important nuances that anyone interested in doing one really needs to know. 

Studies show that abnormal findings are extremely common. More than 95% of asymptomatic individuals have at least one abnormal finding doing whole-body MRI. These may include benign cysts, lipomas, or mild disc bulges in the spine. 

Potentially more significant findings, such as small lung nodules or atypical liver lesions, are also relatively common and often require follow-up imaging. Large studies suggest that 20–30% of individuals fall into this intermediate category where further evaluation is recommended. 

Additionally, false positives – where issues are flagged but are actually benign and non-concerning – are another central concern. A meta-analysis of 12 studies involving more than 5,000 asymptomatic people found that false positives occurred in almost 16% of individuals. These are findings that appear suspicious on imaging but ultimately prove to be benign or clinically insignificant. 

These situations can lead to extended periods of uncertainty and anxiety, along with additional testing that ultimately reveals no significant issue. This not only takes time - for both you and your care team - but may also result in out-of-pocket costs. The emotional impact, however, is often the most significant. 

At the same time, whole-body MRI is not optimized for every organ. For example, low-dose CT remains the reference standard for screenings eligible for high-risk smokers for lung nodules, particularly very small or subsolid lesions.  

There is also no proven mortality benefit for average-risk, asymptomatic adults who undergo a whole-body MRI. Systematic reviews highlight that evidence is still insufficient to show improved survival or population-level outcomes in this group. 

One final limitation is that a single scan protocol is used across the entire body, rather than tailoring the MRI sequences to each specific organ or body region. As a result, the images obtained may not be the most detailed or diagnostically optimal for every area being examined, which can limit the test's effectiveness as a screening tool.

This is why many whole-body MRI reports include notes indicating that certain regions were not assessed using the ideal imaging protocol. Optimizing the scan for each body part would require multiple dedicated MRI sequences and could take many hours to complete. Whole-body MRI prioritizes efficiency, typically capturing images from head to toe in about an hour, but this can come with trade-offs in image quality and diagnostic precision for some regions of the body.

So then, what are the benefits of whole-body MRI? 

Whole-body MRI does well catching abnormalities in bone marrow and soft tissue, where it can detect a range of neoplasms and metastases, especially when standardized protocols are used. 

Roughly 1–2% of people have findings that are highly suspicious of malignancy or other serious diseases. And when these are found, it can lead to early interventions to avoid major conditions. Therefore, it is widely acceptable for high-risk individuals, such as those with strong family histories of cancer, known genetic mutations, or multiple risk factors. These groups stand to benefit the most.  

In some inherited cancer syndromes, whole-body MRI surveillance has been associated with higher survival and earlier-stage detection, which has major potential impact when used in the right context.  

What are whole-body MRI alternatives? 

At Medcan, we offer an option for whole-body MRI through our third-party partner, as a complement and not a replacement, to our Annual Health Assessment, which is a comprehensive review of 100+ biomarkers related to cancer, heart health, metabolic health, mobility, and mind health.   

While today there are multiple solutions for early detection, our approach is comprehensive and offers a full picture of your baseline health. The Annual Health Assessment can also be enhanced with additional screenings such as the Carotid Intima Medial Thickness scan, detailed proactive liver scans, genetic screenings and more. Through this comprehensive approach, we have the ability to help identify disease at earlier stages. 

Although whole-body MRI can offer a meaningful level of detection for people who are comfortable with the possibility of additional tests or unexpected findings, other options for early cancer screening are also available. Medcan recommends that anyone considering whole-body MRI detection considers the Galleri® multi-cancer early detection test as a first step. The Galleri test is much faster, requires only a single blood draw, and can detect up to 50 cancers with a false positive rate of only 0.4%. For more information on the Galleri test, visit this page. 

The Galleri test can also be combined with the evaluations in the Annual Health Assessment, so clients can receive a comprehensive review of their health, along with this extensive screening for cancer. 

Though, most importantly, neither whole-body MRI nor multi-cancer blood tests replace regular guideline-based screenings, and a normal result does not guarantee that an individual does not have cancer.  

Both whole-body MRI and the Galleri test are best used strategically, in combination with established screening and within a comprehensive care plan. 

Who is whole-body MRI for and not for? 

Whole-body MRI is not a diagnostic test for people with symptoms. At Medcan it is only used in select cases as a proactive tool for asymptomatic clients. We have many other evaluations and tests available to support early detection, aligned with Medcan’s Vital Five health pillars – Heart, Cancer, Mind, Movement, and Metabolic such as those offered in our Annual Health Assessment, and our Enhanced Assessments including the Galleri® multi-cancer early detection test. 

For health-conscious adults without known syndromes, a baseline whole-body MRI around age 40 to 50 can help establish a reference point, especially since incidental may become more common with age. However, it is only used when clients understand both the potential benefits and the likelihood of incidental findings that may require monitoring or follow-up. 

Pre-screening is also important. At Medcan, we follow standard safety protocols that include checking for implants, metal fragments, and other contraindications such as pregnancy or severe claustrophobia before suggesting a client proceed 

The optimal interval for repeating whole-body MRI is also not definitively established. Repeating the scan every 1-2 years may be reasonable for those who remain at elevated risk or who have notable findings that require surveillance. 

How Medcan integrates whole-body MRI into care 

At Medcan, our goal is to support responsible access to whole-body MRI amid the growing availability of commercial options. Many health-conscious individuals are already seeking these scans externally, and we aim to ensure that when clients choose whole-body MRI, they do so with informed consent, appropriate pre-test education and clear follow-up pathways. 

At Medcan, we offer whole-body MRI as an add-on to the Annual Health Assessment, rather than as a stand-alone service. We do this to ensure that advanced imaging is embedded in a comprehensive, physician-led evaluation that includes physical examination, blood work, cardiovascular testing, fitness assessments and other imaging where appropriate.  

The Annual Health Assessment  includes age and sex specific screenings alongside a robust set of evidence-based clinical evaluations designed for early disease detection and risk identification. As part of the assessment, individuals receive personalized recommendations and immediate next steps for lifestyle, prevention and treatment. Many of the tests included in this comprehensive evaluation can also identify risks early without the major incidence of false positives. For these reasons, we often suggest this as a foundational assessment for clients who want to be proactive and prevent disease.  

If you are a Dedicated Care member at Medcan, meaning your primary care physician is a Medcan physician, we can also support you with a whole-body MRI through referral to our third-party provider. Through this route, you will be supported by your Dedicated Care physician before and after the process, providing clinical context where additional testing or referrals can be made.  

What should people who want to do a whole-body MRI consider? 

For those considering whole-body MRI, the first step is to clarify what you hope to gain. Some are seeking peace of mind; others want to complement existing screening, and some have specific concerns based on family history or prior findings. Whole-body MRI may or may not be the best option. 

Ultimately, whole-body MRI is most powerful when it is integrated into a comprehensive, evidence-informed program that respects both its potential and its limits. For clients, that means moving beyond the idea of a single “all clear” scan, and toward an ongoing, collaborative approach to proactive health. 

We highly recommend speaking about this solution with a prevention-focused physician such as those at Medcan. If you are booking an Annual Health Assessment, you can speak with our team about the option of including whole-body MRI and discuss whether it is right for you as an enhancement to the assessment. :

Another excellent test to add to a proactive health screening plan is the Calcium Artery Score. More on this to come in my next piece. 

Next Steps 

If you're wondering whether whole-body MRI is the right fit for you, the next step may be to explore some of the alternative approaches discussed above and to speak with a physician who has expertise on the topic and can help guide you accordingly. 

For those seeking a comprehensive view of their health, Medcan's Annual Health Assessment evaluates more than 100 biomarkers across 15 assessment stations. The assessment is built around Medcan’s Vital Five – Heart, Cancer, Mind, Metabolic and Movement – the key pillars of health most closely linked to longevity and quality of life. It includes age- and sex-specific cancer screenings, an abdominal ultrasound, extensive bloodwork, a physician exam and more. Explore this now. 

If your interest in whole-body MRI stems primarily from concerns about cancer, another option to consider is the Galleri Multi-Cancer Early Detection test. Unlike imaging-based screening, Galleri uses a single blood draw to detect a cancer-associated signal for up to 50 types of cancer and can indicate where in the body the signal may be originating. The test is intended to complement, not replace, recommended cancer screening programs and may help identify certain cancers before symptoms develop. Medcan is the exclusive Canadian provider of the Galleri test. To learn more, visit this page. 

Written by Shaun Francis, CEO of Medcan, in collaboration with Medcan's editorial team, and with contribution from Medcan's Head of Clinical Innovation Allison Hazell and Medcan's Vice President of Medical Affairs, Dr. Jason Abrams.

Important Safety Information: The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur.

Lab / Test information: The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. This test is not Health Canada or FDA approved, and has not been endorsed by any professional medical societies at this time.The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

Galleri is a registered trademark of GRAIL, Inc.